FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)

View source ↗

Summary

FDA Supplemental Application for PERTZYE (pancrelipase) submitted by Digestive Care, Inc. under BLA022175. The submission pertains to a supplemental approval pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatic Cancer
• Pancreatitis

Drugs mentioned

• PERTZYE (PANCRELIPASE)

Snippet

SUPPL AP for PERTZYE (PANCRELIPASE)